Log in to search using one of your social media accounts:

 

7 medtech stories we missed this week: Sept. 22, 2017
[Image from unsplash.com]From the FDA’s clearance of Covalon’s film-drape to Bioventus launching its study, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Covalon’s MediClear OTC surgical film-drape Covalon announced in a Sept. 21 press release that the FDA has cleared its MediClear PreOp to market in U.S. hospitals, clinic and directly to patients without a prescription. The MediClear PreOp is a breathable, transparent, self-adhesive, silicone barrier film-drape that can conform to a patient’s skin at a planned incision or insertion si...
Source: Mass Device - September 22, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Business/Financial News Diagnostics Food & Drug Administration (FDA) Laboratory Instruments/Laboratory Supplies mHealth (Mobile Health) Research & Development Vascular Bioventus LLC Contego Medical Covalon Technologies Getinge Guerbe Source Type: news

World Thrombosis Day Webinar: Advances in Reducing the Disease Burden of Thrombosis
October 12, 2017 11:00am ET. (Source: HSR Information Central)
Source: HSR Information Central - September 22, 2017 Category: International Medicine & Public Health Source Type: news

ManaMed Inc. Introduces PlasmaFlow, The World's First FDA-Approved Digital and Tubeless Deep Vein Thrombosis Prevention Device
PlasmaFlow Is Deep Vein Thrombosis (DVT) Prevention Made Simple SANTA ANA, Calif., Sept. 21, 2017 -- (Healthcare Sales & Marketing Network) -- The company's historical first FDA-approved portable and tubeless DVT prevention device is now available to m... Devices, Product Launch ManaMed, PlasmaFlow, Deep Vein Thrombosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2017 Category: Pharmaceuticals Source Type: news

Cardinal Health inks distro deal with Avadim Tech
Life science company Avadim Technologies said yesterday it inked a deal withCardinal Health (NYSE:CAH) to distribute Avadim’s Theraworx topical bionome therapies designed to prevent catheter-associated urinary tract infections and complications. The companies said that the Theraworx topical solution will compliment Cardinal Health’s Dover urological portfolio. “We are honored to partner with one of the most influential leaders in healthcare across the globe. Cardinal Health’s commitment to improving healthcare for more people, in more ways, and in more places than ever before is directly aligne...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Urology Cardinal Health Source Type: news

MassDevice.com +5 | The top 5 medtech stories for September 20, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. The 10 largest medical device companies in the world Mergers & acquisitions continue to change the medical device landscape, as reflected in Medical Design & Outsourcing’s new Big 100 list. We pulled financial reg...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Reva Medical ’s Fantom bioresorbable, drug-eluting vascular scaffold succeeds at 6 months
As some companies have worked to improve drug-eluting stents by making them bioresorbable, some voices in the coronary intervention space have expressed concern over the rates of late stent thrombosis and repeat percutaneous coronary intervention seen with the devices. In a study published in the September issue of JACC: Cardiovascular Intervention, Reva Medical‘s (ASX:RVA) Fantom coronary bioresorbable vascular scaffold succeeded after six months. The device was designed to address challenges like strut size and expansion capacity, the researchers wrote. Get the full story at our sister site, Drug Delivery...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Drug-Device Combinations Drug-Eluting Stents Pharmaceuticals Wall Street Beat Abbott Reva Medical Inc. Source Type: news

DVT (Deep Vein Thrombosis) and Pulmonary Embolism (PE) Quiz
Title: DVT (Deep Vein Thrombosis) and Pulmonary Embolism (PE) QuizCategory: MedicineNet QuizCreated: 7/31/2014 12:00:00 AMLast Editorial Review: 9/20/2017 1:12:43 PM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 20, 2017 Category: Cardiology Source Type: news

Studies support anti-stroke PFO closure devices from Abbott, Gore
Sykes and Clark; licensee BioMed Central Ltd. A trio of studies published this week in the New England Journal of Medicine showed that devices from Abbott (NYSE:ABT) and W.L. Gore & Assoc. designed to close a heart defect lowered the risk of a recurring episode in certain cryptogenic stroke patients. Long-term results from the 980-patient Respect trial of the Amplatzer device Abbott acquired along with St. Jude Medical this year, along with data from the Reduce study of Gore’s Helex and Cardioform and the French Close study of PFO closure devices with CE Mark approval, showed that they reduced the risk of re...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Surgical Abbott Structural heart W.L. Gore & Associates Source Type: news

New European Guidelines for Cerebral Venous Thrombosis New European Guidelines for Cerebral Venous Thrombosis
The guidelines, which cover both the diagnosis and treatment of cerebral venous thrombosis, are based purely on scientific evidence and make several new recommendations, rated as'clear'or'weak. 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Bayer receives positive CHMP opinion for rivaroxaban 10 mg once daily for the extended prevention of venous thromboembolism (for specialized target groups only)
Rivaroxaban 10 mg once daily significantly reduces the risk of recurrent venous thromboembolism compared with aspirin 100 mg once daily after at least six months of standard anticoagulation therapy / Positive CHMP Opinion is based on data from the Phase III EINSTEIN CHOICE study / Final European Commission decision expected by November 2017 (Source: Bayer Company News)
Source: Bayer Company News - September 15, 2017 Category: Pharmaceuticals Source Type: news

Device used to close small hole in heart may protect against recurrent stroke
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial led by UCLA researchers.“It is a major new treatment option for some people,” said Dr. Jeffrey Saver, director of theUCLA Comprehensive Stroke Center and lead author of the study. However, he added, “Using the device is going to have to be a considered clinical decision between the doctor and the patient about who’s the right person to get it.”Thefindings appear in the Sep...
Source: UCLA Newsroom: Health Sciences - September 14, 2017 Category: Universities & Medical Training Source Type: news

Tall people have greater risk of thrombosis
Researchers find strong correlation between height and risk of venous thromboembolism in both women and men Related items fromOnMedica Obese women on the pill more likely to have rare stroke Diagnosis and management of deep vein thrombosis Self-managing anticoagulants may cut risks after surgery Rising use of antithrombotics linked to subdural haematoma (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 12, 2017 Category: UK Health Source Type: news

Taller patients at ‘greater risk’ of venous thromboembolism
The risk of a patient developing venous thromboembolism (VTE) increases with their height, with taller people more likely to experience it, according to Swedish researchers. (Source: Nursing Times)
Source: Nursing Times - September 11, 2017 Category: Nursing Source Type: news

MAUDE: Post-TAVR Leaflet Thrombosis Not Benign MAUDE: Post-TAVR Leaflet Thrombosis Not Benign
While post-TAVR leaflet thrombosis can cause valve dysfunction or even cardiogenic shock and death, the question remains whether there's justification for routine anticoagulation given its inherent risks.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 8, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Recalled in US: Three Lots of Alteplase (Activase), Vial Leakage Hazard Recalled in US: Three Lots of Alteplase (Activase), Vial Leakage Hazard
Genentech says the thrombolytic agent in 100 mg vials was copackaged with sterile water for injection; the water vials may be"cracked or chipped" and no longer sterile.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 7, 2017 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

People over 6ft 2in at higher risk of heart attacks
The Lund University, Sweden, study, which compared siblings to rule out genetic factors, found a direct correlation between height and risk of venous thromboembolism. (Source: the Mail online | Health)
Source: the Mail online | Health - September 6, 2017 Category: Consumer Health News Source Type: news

Blood Disorders
Centers for Disease Control and Prevention. 07/19/2017 This Web page provides links to information, tips, sources, and treatment centers for several blood disorders: Thalassemia, Hemophilia, Sickle Cell Disease, and Thrombosis and Hemostasis. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - September 5, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

ESC: Leaflet Thrombosis Rare After TAVR
(MedPage Today) -- Registry data: most post-procedural valve problems had other causes (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - August 29, 2017 Category: Surgery Source Type: news

Access Vascular raises $4m to support HydroPICC catheter
Medical device developer Access Vascular said today it raised $3.7 million to support its HydroPICC catheter designed to reduce thrombotic risk. The HydroPICC is a peripherally inserted central catheter which the Bedford, Mass.-based company claims can significantly reduce the accumulation of platelets and the risk of thrombosis. Financing will support the submission of an FDA 510(k) application for the company’s HydroPICC device later this year, the company said. “We appreciate the support and engagement of all our investors. This latest round of funding comes at a critical and exciting time for Access Va...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Catheters Vascular accessvascular Source Type: news

Anti-inflammatory therapy cuts risk of lung cancer
In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease. But a recent cardiovascular secondary prevention study has given researchers a unique opportunity: to explore the effectiveness of giving a drug to patients before cancer emerges. At the European Society of Cardiology meeting, Paul M. Ridker, MD, director of the Center for Cardiovascular Disease Prevention at BWH, and colleagues presented findings from CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study). (Source: World Pharma News)
Source: World Pharma News - August 28, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

PCSK9 is a co-activator of platelet function beyond its role in cholesterol homeostasis
(European Society of Cardiology) PCSK9 is a co-activator of platelet function beyond its role in cholesterol homeostasis, according to research presented at ESC Congress today. The findings suggest that PCSK9 inhibitors, a new class of cholesterol-lowering treatments, may also reduce thrombosis by interfering with platelet activation. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 27, 2017 Category: International Medicine & Public Health Source Type: news

The ACS NSQIP Surgical Risk Calculator Has a Role in Predicting Discharge to Post-Acute Care in Total Joint Arthroplasty
A study evaluating the Surgical Risk Tool Calculator, the online tool of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), found that for total joint arthroplasty procedures, the tool is an adequate predictor of discharge to a skilled nursing facility (SNF) or rehabilitation but has limited usefulness for adverse events of 90-day readmission, return to operating room, deep vein thrombosis, and prosthetic joint infection.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - August 26, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

Metastatic Synovial Sarcoma of Lung Mimicking PE and DVT Metastatic Synovial Sarcoma of Lung Mimicking PE and DVT
What can we learn from this case of metastatic synovial sarcoma initially misdiagnosed as deep venous thrombosis?Thorax (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 25, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Cook Medical Issues Recall Correction of Zenith Alpha ™ Thoracic Endovascular Graft and Removes Specific Sizes from the Market
Cook Medical initiated a correction to the Instructions For Use (IFU) for the Zenith Alpha ™ Thoracic Endovascular Graft. This correction removed the indication for blunt thoracic aortic injury, also known as BTAI or “transection” of the aorta because Cook has received an increase in reports of graft thrombosis and occlusion with these grafts specifically in the treatment of BTAI. C ook also initiated a voluntary recall of Zenith Alpha Thoracic products in sizes of 18-22mm, including the 26-22mm tapered device. These specific sizes are primarily used for BTAI, and are no longer available for purchase. (So...
Source: Food and Drug Administration - August 25, 2017 Category: Food Science Source Type: news

Cook Medical Issues Recall Correction of Zenith Alpha ™ Thoracic Endovascular Graft and Removes Specific Sizes from the Market
Cook Medical initiated a correction to the Instructions For Use (IFU) for the Zenith Alpha ™ Thoracic Endovascular Graft. This correction removed the indication for blunt thoracic aortic injury, also known as BTAI or “ transection ” of the aorta because Cook has received an increase in reports of graft thrombosis and occlusion with these grafts specifically in the treatment of BTAI. Cook also initiated a voluntary recall of Zenith Alpha Thoracic products in sizes of 18-22mm, including the 26-22mm tapered device. These specific sizes are primarily used for BTAI, and are no longer available for purchase. (S...
Source: Food and Drug Administration - August 25, 2017 Category: Food Science Source Type: news

Ra Medical CEO Irwin aims for Feb 2018 IPO
In May, Ra Medical received a nod from the FDA for its Dabra arteriosclerosis laser, clearing it for use in the US. It was a decision the company had been waiting on for approximately 3 years, CEO Dean Irwin told MassDevice.com in an interview, and signaled a significant shift forward. “In 2014, we submitted to the FDA, and here in 2017, just on May 24th, we received the go ahead to begin marketing in the United States,” Irwin said. Ra Medical won CE Mark approval in the European Union last October, giving the company time to launch in the region, which it’s been operating in for several mo...
Source: Mass Device - August 24, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Regulatory/Compliance Ra Medical Source Type: news

Ischemic Stroke Complicating Thrombolytic Therapy for STEMI Ischemic Stroke Complicating Thrombolytic Therapy for STEMI
These two cases highlight the rare complication of ischemic stroke following fibrinolytic therapy for STEMI. What mechanism might explain this paradoxical occurrence?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 21, 2017 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Thromboembolism Risk Doubled in Cancer Patients Thromboembolism Risk Doubled in Cancer Patients
Cancer patients are twice as likely as other patients to have an arterial thromboembolic event in the 6 months after diagnosis, although the increased risk disappears at 1 year, say US researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 18, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Online Nursing Education Can Up Patient Use of VTE Prophylaxis
Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 18, 2017 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Critical Care, Nursing, Oncology, Orthopedics, Pharmacy, Pulmonology, Surgery, Journal, Source Type: news

Your NEJM Group Today: Navigating Life After Residency / Thromboembolism in Newly Diagnosed Cancer / New Orleans Hem-Onc Opportunities (FREE)
By the Editors Here's what we chose for you from NEJM Group today:NEJM Knowledge+ Blog: You powered through college to get into medical school. You … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 18, 2017 Category: Primary Care Source Type: news

Cook Medical recalls select Zenith Alpha endo grafts
The FDA today released information on a recall of Cook Medical’s Zenith Alpha thoracic endovascular graft designed for treating blunt traumatic aortic injury over issues with thrombus formation, classifying the recall as Class I. Class I recall designations, the FDA’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The Zenith Alpha thoracic endovascular graft is designed to treat isolated lesions in main blood vessels that carry blood from the heart through the chest into the abdomen, and is used in...
Source: Mass Device - August 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Recalls Vascular Cook Medical Source Type: news

#Recall: Cook Medical Inc. Zenith Alpha Thoracic Endovascular Graft for BTAI - Potential Formation of Thrombus https://go.usa.gov/xRdut  
#Recall: Cook Medical Inc. Zenith Alpha Thoracic Endovascular Graft for BTAI - Potential Formation of Thrombus https://go.usa.gov/xRdut  (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - August 16, 2017 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

For post-menopausal women, vaginal estrogens do not raise risk of cancer, other diseases
This study, the first to examine potential adverse health effects in users of vaginal estrogen compared with non-users, suggests that vaginal estrogen therapy is a safe treatment for genitourinary symptoms such as burning, discomfort, and pain during intercourse associated with menopause.AUTHORSThe paper ’s authors are Dr. Carolyn Crandall of UCLA; Kathleen Hovey of the State University of New York at Buffalo; Christopher Andrews of the University of Michigan; Dr. Rowan Chlebowski of City of Hope; Marcia Stefanick of Stanford University; Dr. Dorothy Lane of the State University of New York at Ston y Brook; Dr. Jan Sh...
Source: UCLA Newsroom: Health Sciences - August 16, 2017 Category: Universities & Medical Training Source Type: news

Cancer Diagnosis Boosts Risk for MI (CME/CE)
(MedPage Today) -- Risk of arterial thromboembolism doubles in 6 months, study finds (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 15, 2017 Category: Cardiology Source Type: news

Short - Term Risk of Arterial Embolism Up in Cancer Patients
Increased risk of arterial thromboembolism, MI, ischemic stroke for cancer patients (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 15, 2017 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Internal Medicine, Critical Care, Emergency Medicine, Neurology, Oncology, Journal, Source Type: news

New cancer diagnosis may come with risk of thromboembolism
(American College of Cardiology) Patients newly diagnosed with cancer may have a substantially increased short-term risk of arterial thromboembolism, according to a study published today in the Journal of the American College of Cardiology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 14, 2017 Category: Cancer & Oncology Source Type: news

Nasal sprays prevent deep vein thrombosis on flights
Researchers from the University of Birmingham found that anti-allergy drugs that suppress certain immune cells protect mice from DVT, which affects around 600,000 each year in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - August 3, 2017 Category: Consumer Health News Source Type: news

Deep vein thrombosis cure? THIS could treat blood clots in the legs
DEEP vein thrombosis - blood clots in the legs - could be treated with common allergy medicine. (Source: Daily Express - Health)
Source: Daily Express - Health - August 2, 2017 Category: Consumer Health News Source Type: news

Deep vein thrombosis: Anti-allergy medicines could be an effective treatment
COMMON anti-allergy medicines could be an effective treatment for deep vein thrombosis, new research suggests. (Source: Daily Express - Health)
Source: Daily Express - Health - August 2, 2017 Category: Consumer Health News Source Type: news

Gore touts reduced portal hypertension, complications in Viatorr Tips trial
W.L. Gore & Associates today released preliminary data from a trial of its Viatorr Tips endoprosthesis with controlled expansion, touting reduced portal hypertension treatment complications when compared to the company’s legacy Tips device and bare metal stents. Data from the study was presented at The International Liver Congress 2017 in Amsterdam, the Flagstaff, Ariz.-based company said. Preliminary data from the trial, which has 21 patients currently and is still enrolling, also indicated a reduction in hospital admissions from cirrhosis-related complications, including refractory ascites and sepsis, when the ...
Source: Mass Device - August 1, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Stent Grafts Stents Vascular W.L. Gore & Associates Source Type: news

Cardinal Health closes $6B buy of Medtronic patient care, DVT and nutritional insufficiency biz
Cardinal Health (NYSE:CAH) said today it closed its $6.1 billion acquisition of Medtronic‘s (NYSE:MDT) patient care, deep vein thrombosis and nutritional insufficiency business. Dublin, Ohio-based Cardinal Health said that the acquisition was funded through a combined $4.5 billion in new senior unsecured notes alongside existing cash and borrowings from credit facilities. The deal includes a total of 23 product categories across multiple market sites of care, Cardinal Health said, including the brands Curity, Kendall, Dover, Argyle and Kangaroo. Cardinal Health said it expects the acquisition to be accretive to ...
Source: Mass Device - July 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Cardinal Health Medtronic Source Type: news

Treatment of VTE Varies Widely Treatment of VTE Varies Widely
Treatment of venous thromboembolism varies widely, reflecting the broad heterogeneity among patients, a new study shows, underlining the need for individualized therapy, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 26, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Is it safe to fly after getting deep vein thrombosis
Swelling of the leg following a DVT can persist for many months, even a year or more, but be reassured — it is not a sign of anything sinister. (Source: the Mail online | Health)
Source: the Mail online | Health - July 24, 2017 Category: Consumer Health News Source Type: news

Medical News Today: What is a thrombus? Causes and types
What is a thrombus? In this article, we explore the different types of thrombus, their causes and symptoms, and how they are diagnosed and treated. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 22, 2017 Category: Consumer Health News Tags: Vascular Source Type: news

FDA recalls Penumbra 3D Revascularization device over wire separation issues
The FDA today released a recall notice for Penumbra‘s (NYSE:PEN) 3D Revascularization Device, part of its Penumbra system designed to remove thrombus from brain blood vessels during strokes, over issues with wire breaks and separations. The FDA labeled the recall as Class I, its most serious designation, indicating that there is a reasonable probability that use of the product could cause serious adverse health consequences or death. The 3D Revascularization device is designed to restore blood flow or remove blood clots in blood vessels in the brain during acute ischemic stroke in patients who are ineligible or ...
Source: Mass Device - July 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Neurological Recalls Vascular Penumbra Inc. Source Type: news

Early, Late Stent Thrombosis Look Different on OCT
(MedPage Today) -- Optical coherence tomography shows variance in mechanism (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 20, 2017 Category: Cardiology Source Type: news

Shorter Compression Stocking Time May Be OK for Some With DVT Shorter Compression Stocking Time May Be OK for Some With DVT
Serial evaluation using signs and symptoms scores can indicate which patients with deep vein thrombosis may be able to use compression stockings for less than 2 years, a randomized study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 20, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Absorb's Risk for Very Late Events Affirmed Across Trials (CME/CE)
(MedPage Today) -- Target vessel MI, stent thrombosis problems persist in meta-analysis (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 19, 2017 Category: American Health Source Type: news

Risk factors for deep vein thrombosis and pulmonary embolism after traumatic injury: a competing risks analysis - Van Gent JM, Calvo RY, Zander AL, Olson EJ, Sise CB, Sise MJ, Shackford SR.
BACKGROUND: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is typically reported as a composite measure of the quality of trauma center care. Given recent data suggesting post-injury DVT and PE are distinct ... (Source: SafetyLit)
Source: SafetyLit - July 15, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

The LAA: From Embryology to Prevention of Thromboembolism The LAA: From Embryology to Prevention of Thromboembolism
The left atrial appendage is the main source of thromboembolism in patients with non-valvular AF. Review its function, imaging, and significance in this article.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news